Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatogenesis-associated protein 1 (SPATA1) is a protein highly expressed in the testis and involved in the process of spermatogenesis and spermiogenesis, particularly during acrosome development in male germ cells. It is most abundant in developing germ cells (spermatids) and localizes to the acrosomal region. SPATA1 is a binding partner of intraflagellar transport protein 20 (IFT20), possibly providing a docking site for the IFT20 complex at the acrosome area. The protein is also expressed at lower levels in other tissues such as kidney, heart, brain, and lung. Although its role is specific to germ cell development and acrosome formation, there is currently no evidence demonstrating its direct therapeutic targeting or association with major diseases, but it may serve as a marker for male fertility assessment[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis-associated protein 1 (SPATA1).